# Metabomed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/metabomed

- Industry: Pharmaceuticals
- Headquarters: Yavne, Israel
- Website: www.metabomed.com
- Total disclosed funding: $31M
- Latest round: Series B (Dec 19, 2019)
- Investors on record: 8

## About

Established in 2013 and based in Yavne, Israel, Metabomed is a biotechnology company that focuses on the discovery and development of potential small molecule drugs directed against novel targets in the field of cancer metabolism.

## Funding rounds

- Series B, Dec 19, 2019, $13M — Pontifax Venture Capital, Boehringer Ingelheim Venture, Pfizer Venture Investments, Yonghua Capital, Arkin Capital, M Ventures
- Series A, Apr 4, 2016, $18M — Pontifax Venture Capital, M Ventures, Boehringer Ingelheim Venture, Pfizer Inc., Technion Research & Development Foundation, Arkin Capital
- Seed, Nov 26, 2013 — Pontifax Venture Capital, M Ventures, Boehringer Ingelheim Venture, Technion Research & Development Foundation

## Investors

- Pontifax Venture Capital (https://capitalatlas.ai/funds/pontifax-venture-capital) — Seed, Series A, Series B
- M Ventures (https://capitalatlas.ai/funds/m-ventures) — Seed, Series A, Series B
- Boehringer Ingelheim Venture (https://capitalatlas.ai/funds/boehringer-ingelheim-venture) — Seed, Series A, Series B
- Technion Research & Development Foundation — Seed, Series A
- Pfizer Inc. — Series A
- Arkin Capital (https://capitalatlas.ai/funds/arkin-capital) — Series A, Series B
- Pfizer Venture Investments (https://capitalatlas.ai/funds/pfizer-venture-investments) — Series B
- Yonghua Capital (https://capitalatlas.ai/funds/yonghua-capital) — Series B